Incyte Corporation
(INCY)
|
13.6 |
$1.5B |
|
15M |
104.21 |
Seattle Genetics
|
13.1 |
$1.5B |
|
31M |
48.40 |
Alexion Pharmaceuticals
|
10.4 |
$1.2B |
|
6.5M |
180.77 |
Abbvie
(ABBV)
|
8.5 |
$966M |
|
14M |
67.19 |
ACADIA Pharmaceuticals
(ACAD)
|
7.5 |
$858M |
|
21M |
41.88 |
Incyte Corporation Notes 1.25% 11/15/2020 144A Conv Bonds (Principal)
|
5.0 |
$568M |
|
275M |
2.07 |
BioMarin Pharmaceutical
(BMRN)
|
4.9 |
$560M |
|
4.1M |
136.78 |
Incyte Corporation Notes 0.375% 11/15/2018 144A Conv Bonds (Principal)
|
4.6 |
$530M |
|
259M |
2.04 |
Incyte Corporation Notes 4.75% 10/1/2015 144A Conv Bonds (Principal)
|
4.2 |
$479M |
|
40M |
11.84 |
Genomic Health
|
3.3 |
$380M |
|
14M |
27.79 |
Anacor Pharmaceuticals In
|
2.5 |
$281M |
|
3.6M |
77.43 |
Dyax
|
1.8 |
$210M |
|
7.9M |
26.50 |
BioCryst Pharmaceuticals
(BCRX)
|
1.5 |
$173M |
|
12M |
14.93 |
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 Conv Bonds (Principal)
|
1.3 |
$150M |
|
22M |
6.70 |
Gilead, Inc. 1.625% 5/1/16 Conv Bonds (Principal)
|
0.9 |
$108M |
|
21M |
5.15 |
Invitae
(NVTAQ)
|
0.9 |
$98M |
|
6.6M |
14.88 |
Bellicum Pharma
|
0.8 |
$89M |
|
4.2M |
21.27 |
Mirati Therapeutics
|
0.8 |
$88M |
|
2.8M |
31.47 |
Heron Therapeutics
(HRTX)
|
0.8 |
$88M |
|
2.8M |
31.16 |
Spark Therapeutics
|
0.7 |
$76M |
|
1.3M |
60.27 |
Medivation, Inc. 2.625% 4/1/17 Conv Bonds (Principal)
|
0.7 |
$75M |
|
34M |
2.21 |
Cerus Corporation
(CERS)
|
0.6 |
$70M |
|
14M |
5.19 |
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 Conv Bonds (Principal)
|
0.5 |
$60M |
|
60M |
1.01 |
XOMA CORP Common equity shares
|
0.5 |
$57M |
|
15M |
3.88 |
DBV Technologies Sponsored Adr
(DBVT)
|
0.5 |
$56M |
|
1.9M |
29.78 |
Versartis
|
0.5 |
$52M |
|
3.4M |
15.22 |
Alder Biopharmaceuticals
|
0.4 |
$47M |
|
892k |
52.97 |
Halozyme Therapeutics
(HALO)
|
0.4 |
$44M |
|
1.9M |
22.58 |
Atyr Pharma Inc Common Stock Usd 0.001
|
0.4 |
$43M |
|
2.3M |
18.52 |
XenoPort
|
0.3 |
$40M |
|
6.5M |
6.13 |
Array BioPharma
|
0.3 |
$40M |
|
5.5M |
7.21 |
Insmed
(INSM)
|
0.3 |
$39M |
|
1.6M |
24.42 |
Sangamo Biosciences
(SGMO)
|
0.3 |
$36M |
|
3.2M |
11.09 |
ImmunoGen
|
0.3 |
$33M |
|
2.3M |
14.38 |
Tg Therapeutics
(TGTX)
|
0.3 |
$33M |
|
2.0M |
16.59 |
Progenics Pharmaceuticals
|
0.3 |
$33M |
|
4.4M |
7.46 |
Catalyst Pharmaceutical Partners
(CPRX)
|
0.3 |
$30M |
|
7.3M |
4.13 |
Gilead Sciences
(GILD)
|
0.3 |
$29M |
|
250k |
117.08 |
Kythera Biopharmaceuticals I
|
0.3 |
$29M |
|
388k |
75.31 |
Neurocrine Biosciences
(NBIX)
|
0.2 |
$26M |
|
542k |
47.76 |
Idera Pharmaceuticals
|
0.2 |
$26M |
|
7.0M |
3.71 |
Bluebird Bio
(BLUE)
|
0.2 |
$25M |
|
151k |
168.37 |
Derma Sciences
|
0.2 |
$25M |
|
3.5M |
7.16 |
Acorda Therapeutics
|
0.2 |
$25M |
|
739k |
33.33 |
Novavax
|
0.2 |
$22M |
|
1.9M |
11.14 |
Foamix Pharmaceuticals SHS
|
0.2 |
$21M |
|
2.0M |
10.25 |
Xencor
(XNCR)
|
0.2 |
$19M |
|
872k |
21.97 |
Galapagos NV Sponsored Adr
(GLPG)
|
0.2 |
$19M |
|
369k |
51.50 |
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 Conv Bonds (Principal)
|
0.2 |
$19M |
|
12M |
1.55 |
Clovis Oncology
|
0.2 |
$18M |
|
203k |
87.88 |
Omeros Corporation
(OMER)
|
0.2 |
$17M |
|
965k |
17.99 |
Zogenix
|
0.1 |
$17M |
|
10M |
1.68 |
Lion Biotechnologies
|
0.1 |
$17M |
|
1.8M |
9.17 |
ProQR Therapeutics SHS
(PRQR)
|
0.1 |
$17M |
|
988k |
16.67 |
Repros Therapeutics
|
0.1 |
$14M |
|
2.0M |
7.15 |
Achillion Pharmaceuticals
|
0.1 |
$14M |
|
1.5M |
8.86 |
Ultragenyx Pharmaceutical
(RARE)
|
0.1 |
$13M |
|
124k |
102.39 |
Threshold Pharmaceuticals
|
0.1 |
$12M |
|
2.9M |
4.04 |
Alcobra SHS
|
0.1 |
$12M |
|
1.8M |
6.54 |
Macrogenics
(MGNX)
|
0.1 |
$12M |
|
305k |
37.97 |
Agios Pharmaceuticals
(AGIO)
|
0.1 |
$11M |
|
100k |
111.14 |
La Jolla Pharmaceuticl Com Par
|
0.1 |
$10M |
|
412k |
24.51 |
Zafgen
|
0.1 |
$10M |
|
288k |
34.63 |
Osiris Therapeutics
|
0.1 |
$9.7M |
|
499k |
19.46 |
Sunesis Pharmaceuticals
|
0.1 |
$9.6M |
|
3.2M |
3.01 |
Ignyta
|
0.1 |
$8.6M |
|
571k |
15.09 |
Aquinox Pharmaceuticals
|
0.1 |
$8.3M |
|
1.2M |
6.94 |
Sage Therapeutics
(SAGE)
|
0.1 |
$7.7M |
|
105k |
73.00 |
Ligand Pharmaceuticals In
(LGND)
|
0.1 |
$7.4M |
|
73k |
100.90 |
Concert Pharmaceuticals I equity
|
0.1 |
$7.4M |
|
496k |
14.89 |
Arrowhead Research
|
0.1 |
$7.2M |
|
1.0M |
7.15 |
Karyopharm Therapeutics
(KPTI)
|
0.1 |
$5.9M |
|
217k |
27.21 |
Epizyme
|
0.0 |
$5.6M |
|
233k |
24.00 |
Amarin Corporation Sponsored Adr
(AMRN)
|
0.0 |
$5.4M |
|
2.2M |
2.46 |
Affimed Therapeutics B V
|
0.0 |
$5.4M |
|
400k |
13.47 |
Chimerix
(CMRX)
|
0.0 |
$5.3M |
|
115k |
46.20 |
Aerie Pharmaceuticals
|
0.0 |
$5.3M |
|
299k |
17.65 |
Vanda Pharmaceuticals
(VNDA)
|
0.0 |
$5.2M |
|
410k |
12.69 |
Seres Therapeutics
(MCRB)
|
0.0 |
$5.2M |
|
125k |
41.50 |
Cytrx
|
0.0 |
$4.9M |
|
1.3M |
3.72 |
Assembly Biosciences
|
0.0 |
$4.8M |
|
250k |
19.26 |
Receptos
|
0.0 |
$4.5M |
|
24k |
190.04 |
Juno Therapeutics
|
0.0 |
$4.3M |
|
80k |
53.33 |
D Stemline Therapeutics
|
0.0 |
$3.9M |
|
334k |
11.77 |
NeuroDerm Ord Shs
|
0.0 |
$3.8M |
|
250k |
15.35 |
Array BioPharma Inc. Notes 3.0% 6/1/2020 Conv Bonds (Principal)
|
0.0 |
$3.8M |
|
3.0M |
1.26 |
Curis
|
0.0 |
$3.6M |
|
1.1M |
3.31 |
Enanta Pharmaceuticals
(ENTA)
|
0.0 |
$3.4M |
|
75k |
44.99 |
Intra Cellular Therapies
(ITCI)
|
0.0 |
$3.3M |
|
104k |
31.95 |
ISIS Pharmaceuticals
|
0.0 |
$3.3M |
|
57k |
57.54 |
Proteon Therapeutics
|
0.0 |
$3.2M |
|
177k |
17.86 |
Immune Design
|
0.0 |
$3.1M |
|
149k |
20.65 |
Bellerophon Therapeutics
|
0.0 |
$2.8M |
|
350k |
7.93 |
Vitae Pharmaceuticals
|
0.0 |
$2.7M |
|
188k |
14.40 |
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 Conv Bonds (Principal)
|
0.0 |
$2.6M |
|
3.4M |
0.76 |
Discovery Laboratories
|
0.0 |
$2.4M |
|
3.6M |
0.68 |
Marinus Pharmaceuticals
|
0.0 |
$2.3M |
|
200k |
11.60 |
Mast Therapeutics
|
0.0 |
$2.3M |
|
4.7M |
0.49 |
ZIOPHARM Oncology
|
0.0 |
$2.3M |
|
189k |
12.00 |
Tekmira Pharmaceuticals Corporation
|
0.0 |
$2.1M |
|
181k |
11.86 |
Aurinia Pharmaceuticals
(AUPH)
|
0.0 |
$2.1M |
|
712k |
2.99 |
Ironwood Pharmaceuticals
(IRWD)
|
0.0 |
$2.0M |
|
169k |
12.06 |
Ophthotech
|
0.0 |
$1.9M |
|
36k |
52.06 |
Adaptimmune Therapeutics Sponsored Adr
(ADAP)
|
0.0 |
$1.8M |
|
100k |
18.33 |
Palatin Technologies
|
0.0 |
$1.8M |
|
2.1M |
0.89 |
Cellectis Sponsored Adr
(CLLS)
|
0.0 |
$1.8M |
|
50k |
36.08 |
Loxo Oncology
|
0.0 |
$1.8M |
|
100k |
18.03 |
Ritter Pharmaceuticals
|
0.0 |
$1.8M |
|
400k |
4.45 |
Ascendis Pharma A/S Sponsored Adr
(ASND)
|
0.0 |
$1.8M |
|
100k |
17.68 |
Dermira
|
0.0 |
$1.8M |
|
100k |
17.55 |
Biota Pharmaceuticals
|
0.0 |
$1.7M |
|
830k |
2.07 |
BioDelivery Sciences International
|
0.0 |
$1.7M |
|
210k |
7.96 |
MediWound Ord Shs
|
0.0 |
$1.6M |
|
225k |
7.07 |
Alnylam Pharmaceuticals
(ALNY)
|
0.0 |
$1.4M |
|
11k |
119.84 |
Tenax Therapeutics
|
0.0 |
$1.3M |
|
355k |
3.69 |
Aldeyra Therapeutics
(ALDX)
|
0.0 |
$1.1M |
|
142k |
7.76 |
Ohr Pharmaceutical
|
0.0 |
$930k |
|
370k |
2.51 |
Acceleron Pharma
|
0.0 |
$910k |
|
29k |
31.64 |
UniQure B.V. SHS
(QURE)
|
0.0 |
$810k |
|
30k |
27.00 |
Foundation Medicine
|
0.0 |
$707k |
|
21k |
33.84 |
Achaogen
|
0.0 |
$603k |
|
100k |
6.03 |
Five Prime Therapeutics
|
0.0 |
$478k |
|
19k |
24.84 |
Chemocentryx
|
0.0 |
$404k |
|
49k |
8.23 |
Aptose Biosciences
|
0.0 |
$170k |
|
33k |
5.09 |
Cyclacel Pharmaceuticals, Inc. Pfd. Conv. Ex 6% Pfd Conv Ex 6%
(CYCCP)
|
0.0 |
$85k |
|
13k |
6.41 |
BioTime, Inc. Rights Warrants
|
0.0 |
$23k |
|
20k |
1.15 |